abbvie glp-1 receptor agonist weight management diabetes treatments agonists GLP-1 Agonists: Revolutionizing the Treatment of GLP-1 Injections for Medical Weight

E., Nascimento, J

This precision approach helps prioritize which strategiesdietary, behavioral, or pharmacologicalalign best with individual biology

doi: 10.1126/scitranslmed.3007218 [DOI] [PubMed] [Google Scholar] 45

established cardiovascular disease [CVD], 84.7%

Patients were initially eligible for surgery if they had a BMI of 40 kg/m 2 or higher, or a BMI between 35 and 40 kg/m 2 with significant comorbidities according to French guidelines [27]

Activation of glucagon-like peptide-1 receptor in microglia exerts protective effects against sepsis-induced encephalopathy via attenuating endoplasmic reticulum stress-associated inflammation and apoptosis in a mouse model of sepsis